Diagnostic Imaging Devices - Malta

The Diagnostic Imaging Devices market market in Malta is anticipated to achieve a revenue of US$6.82m by the year 2024.
It is predicted that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 6.56%, leading to a market volume of US$9.36m by 2029.
When compared globally, the United States is expected to generate the highest revenue of US$11.93bn in 2024.
Malta is experiencing a growing demand for advanced diagnostic imaging devices in its medical technology market.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Malta is experiencing steady growth due to customer preferences for advanced medical technology, increasing demand for early disease detection, and the presence of local special circumstances. Customer preferences in the Diagnostic Imaging Devices market in Malta are driving the demand for advanced medical technology. Patients and healthcare professionals in Malta are increasingly seeking state-of-the-art diagnostic imaging devices that provide accurate and detailed results. This preference for advanced technology is fueled by the desire for early disease detection and timely medical intervention. As a result, there is a growing demand for imaging devices with high resolution, improved image quality, and advanced features such as 3D imaging and real-time monitoring. The trends in the Diagnostic Imaging Devices market in Malta are aligned with the global market trends. There is a growing emphasis on non-invasive diagnostic procedures, which has led to an increased adoption of imaging devices such as MRI scanners, CT scanners, and ultrasound machines. These devices offer a non-invasive and painless way to diagnose various medical conditions, reducing the need for invasive procedures and minimizing patient discomfort. Additionally, there is a rising demand for portable and handheld imaging devices, which offer convenience and flexibility in healthcare settings with limited space or in remote areas. Local special circumstances in Malta contribute to the development of the Diagnostic Imaging Devices market. Malta has a well-established healthcare system and is known for its high-quality medical services. The presence of advanced healthcare facilities and skilled medical professionals creates a conducive environment for the adoption of diagnostic imaging devices. Furthermore, Malta's aging population and increasing prevalence of chronic diseases drive the demand for diagnostic imaging devices, as these devices play a crucial role in the early detection and monitoring of such conditions. Underlying macroeconomic factors also play a role in the growth of the Diagnostic Imaging Devices market in Malta. The country has a stable economy and a favorable business environment, which attracts foreign investments and encourages the establishment of medical device companies. Additionally, the government of Malta has implemented policies to promote healthcare innovation and technology adoption, further supporting the growth of the diagnostic imaging market. In conclusion, the Diagnostic Imaging Devices market in Malta is developing due to customer preferences for advanced medical technology, the global trend towards non-invasive diagnostic procedures, local special circumstances such as a well-established healthcare system, and underlying macroeconomic factors. The market is expected to continue growing as the demand for accurate and efficient diagnostic imaging devices increases in Malta.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.